v3.10.0.1
CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Operating expenses:        
Research and development $ 1,449,508 $ 1,339,039 $ 2,311,928 $ 2,677,643
General and administrative 4,314,552 1,676,336 6,086,348 3,233,677
Depreciation 2,926 2,997 5,829 6,066
Total operating expenses 5,766,986 3,018,372 8,404,105 5,917,386
Loss from operations (5,766,986) (3,018,372) (8,404,105) (5,917,386)
Other income (expense):        
Loss on change in fair value of derivatives 0 (60,244) 0 (433,855)
Interest income 263 54 348 54
Loss before income taxes (5,766,723) (3,078,562) (8,403,757) (6,351,187)
Income taxes (benefit) 0 0 0 0
Net loss (5,766,723) (3,078,562) (8,403,757) (6,351,187)
Preferred stock dividend (280,867) (22,863) (585,913) (46,608)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (6,047,590) $ (3,101,425) $ (8,989,670) $ (6,397,795)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.18) $ (0.12) $ (0.28) $ (0.27)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 34,518,208 25,131,486 32,243,961 24,097,424

Source